| Paxlovid |
Human |
nirmatrelvir;ritonavir |
nirmatrelvir;ritonavir |
EMEA/H/C/005973 |
Pfizer Europe MA EEIG |
2022/01/28
|
Authorised |
| Vyepti |
Human |
eptinezumab |
Eptinezumab |
EMEA/H/C/005287 |
H. Lundbeck A/S |
2022/01/24
|
Authorised |
| Voraxaze |
Human |
glucarpidase |
glucarpidase |
EMEA/H/C/005467 |
SERB SAS |
2022/01/11
|
Authorised |
| Skytrofa (previously Lonapegsomatropin Ascendis Pharma) |
Human |
lonapegsomatropin |
Lonapegsomatropin |
EMEA/H/C/005367 |
Ascendis Pharma Endocrinology Division A/S |
2022/01/11
|
Authorised |
| Tavneos |
Human |
avacopan |
avacopan |
EMEA/H/C/005523 |
Vifor Fresenius Medical Care Renal Pharma France |
2022/01/11
|
Authorised |
| Tecovirimat SIGA |
Human |
tecovirimat monohydrate |
tecovirimat |
EMEA/H/C/005248 |
SIGA Technologies Netherlands B.V. |
2022/01/06
|
Authorised |
| Riltrava Aerosphere |
Human |
formoterol fumarate dihydrate;glycopyrronium;budesonide |
Budesonide;formoterol fumarate dihydrate;glycopyrronium bromide |
EMEA/H/C/005311 |
AstraZeneca AB |
2022/01/06
|
Authorised |
| Wegovy |
Human |
semaglutide |
semaglutide |
EMEA/H/C/005422 |
Novo Nordisk A/S |
2022/01/06
|
Authorised |
| Lumykras |
Human |
sotorasib |
sotorasib |
EMEA/H/C/005522 |
Amgen Europe B.V. |
2022/01/06
|
Authorised |
| Nuvaxovid |
Human |
COVID-19 Vaccine (recombinant, adjuvanted) |
SARS CoV-2 (Original) recombinant spike protein;SARS-CoV-2 (Omicron XBB.1.5) recombinant spike protein |
EMEA/H/C/005808 |
Sanofi Winthrop Industrie |
2021/12/20
|
Authorised |
| Xevudy |
Human |
sotrovimab |
sotrovimab |
EMEA/H/C/005676 |
GlaxoSmithKline Trading Services Limited |
2021/12/17
|
Authorised |
| Aspaveli |
Human |
pegcetacoplan |
pegcetacoplan |
EMEA/H/C/005553 |
Swedish Orphan Biovitrum AB (publ) |
2021/12/13
|
Authorised |
| Vaxneuvance |
Human |
pneumococcal polysaccharide conjugate vaccine (adsorbed) |
pneumococcal polysaccharide conjugate vaccine (adsorbed) |
EMEA/H/C/005477 |
Merck Sharp & Dohme B.V. |
2021/12/13
|
Authorised |
| Sitagliptin SUN |
Human |
sitagliptin fumarate |
sitagliptin fumarate |
EMEA/H/C/005741 |
Sun Pharmaceutical Industries Europe B.V. |
2021/12/09
|
Authorised |
| Rybrevant |
Human |
amivantamab |
amivantamab |
EMEA/H/C/005454 |
Janssen-Cilag International N.V. |
2021/12/09
|
Authorised |
| Cibinqo |
Human |
abrocitinib |
abrocitinib |
EMEA/H/C/005452 |
Pfizer Europe MA EEIG |
2021/12/09
|
Authorised |
| Brukinsa |
Human |
zanubrutinib |
zanubrutinib |
EMEA/H/C/004978 |
BeOne Medicines Ireland Limited |
2021/11/22
|
Authorised |
| Trodelvy |
Human |
sacituzumab govitecan |
sacituzumab govitecan |
EMEA/H/C/005182 |
Gilead Sciences Ireland UC |
2021/11/22
|
Authorised |
| Artesunate Amivas |
Human |
artesunate |
artesunate |
EMEA/H/C/005550 |
Amivas Ireland Ltd |
2021/11/22
|
Authorised |
| Qinlock |
Human |
ripretinib |
ripretinib |
EMEA/H/C/005614 |
Deciphera Pharmaceuticals (Netherlands) B.V. |
2021/11/18
|
Authorised |